Published in Dtsch Med Wochenschr on January 05, 2007
[beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study]. Dtsch Med Wochenschr (2007) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Complex chronic comorbidities of COPD. Eur Respir J (2008) 3.84
Physical activity in patients with COPD. Eur Respir J (2008) 3.75
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J (2004) 3.19
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03
Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis (1992) 2.89
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J (2001) 2.77
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. Eur Respir J (2009) 2.54
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. BMJ (1992) 2.48
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J (2011) 2.38
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Body plethysmography--its principles and clinical use. Respir Med (2011) 2.15
Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax (2009) 2.12
Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol (2007) 1.99
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol (1991) 1.98
Changes in sputum composition between two inductions performed on consecutive days. Thorax (1998) 1.98
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med (2003) 1.97
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J (2004) 1.91
Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course - the GINIplus study up to the age of 6 years. Clin Exp Allergy (2010) 1.90
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol (1985) (1993) 1.88
Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation (2000) 1.84
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy (2005) 1.76
Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur Respir J (2007) 1.76
Nasal CPAP therapy: effects of different CPAP levels on pressure transmission into the trachea and pulmonary oxygen transfer. Acta Anaesthesiol Scand (2002) 1.76
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology (2001) 1.75
A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71
Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med (2010) 1.65
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64
COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract (2014) 1.63
Assessment of accuracy and applicability of a new electronic peak flow meter and asthma monitor. Eur Respir J (1998) 1.62
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer (2006) 1.61
Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J (2007) 1.60
[Guidelines for diagnosis and treatment of asthma patients]. Pneumologie (2006) 1.59
Alcoholism: the keys to the CAGE. Am J Med (1993) 1.59
Acute effect of passive smoking on lung function and airway responsiveness in asthmatic children. Pediatr Pulmonol (1991) 1.58
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life. Allergy (2009) 1.54
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy (2005) 1.51
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J (1994) 1.49
[Asthma therapy in children and adults. Recommendations of the German Respiratory League of the German Society of Pneumology]. Med Klin (Munich) (1998) 1.47
Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis? Eur Respir J (2003) 1.47
Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study. Clin Exp Allergy (1992) 1.46
[Recommendations of the German Respiratory Tract League on asthma management of adults and children. The German Respiratory Tract League]. Med Klin (Munich) (1994) 1.45
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J (2006) 1.45
Value and limits of Graham's law for prediction of diffusivities of gases in gas mixtures. Respir Physiol (1980) 1.44
Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy (2009) 1.42
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J (1994) 1.42
Indirect airway challenges. Eur Respir J (2003) 1.42
[Guidelines to long-term oxygen therapy]. Pneumologie (2001) 1.41
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases]. Med Klin (Munich) (1991) 1.41
[Guideline-adherent treatment for asthma]. Internist (Berl) (2008) 1.40
[Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie (2006) 1.40
[Effects of the oxidizing agents ozone and nitrogen dioxide on the lung: studies of a cell culture model]. Immun Infekt (1995) 1.39
[Rare diseases in pulmonary medicine and its challenges]. Pneumologie (2012) 1.39
Reproterol: beta-2-agonist, theophylline, or both? Respiration (1999) 1.39
[Omalizumab therapy in adolescents with severe allergic asthma - results of a post-marketing surveillance]. Pneumologie (2013) 1.38
[Hematothorax after sudden chest pain]. Dtsch Med Wochenschr (2006) 1.38
[Infection diagnostics in pneumology. Part 1. Survey and methods]. Pneumologie (2008) 1.38
[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Pneumologie (1999) 1.38
[Chronic obstructive pulmonary disease (COPD)]. Dtsch Med Wochenschr (2012) 1.38
Histamine hypersensitivity induced by passive sensitization of human bronchus: effect of serum IgE depletion. Clin Exp Allergy (1998) 1.38
Monitoring theophylline levels in serum and saliva using fluorescence polarization immunoassay and Seralyzer. Pediatr Pulmonol (1989) 1.37
Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J (1997) 1.36
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med (1996) 1.33
Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration (2011) 1.33
Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med (1996) 1.33
Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J (2004) 1.32
Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol (1998) 1.31
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 1.31
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J (2007) 1.30
Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol (1991) 1.30